Delivery Order SPE2DB20D3103-SPE2DB24FM8V6
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, with a potential value of $1,079.76 and a completion date of February 6, 2024. The order is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $1,556.56, has an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation, to provide NARCAN 4 mg nasal spray. The contract has a potential value of $1,602.48 and a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) awarded by...
- This is a $1,102.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has an ultimate completion date of July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- This is a $2,530.77 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. The contract has a performance period through July 7, 2025 and is not set aside. Amerisourcebergen also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, allowing the company to supply a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,761.76 firm fixed price delivery order contract to supply NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has a period of performance through February 8, 2024 and a potential value of $1,079.76. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The delivery order has a ceiling value of $3,183.36 and a period of performance through March 28, 2024. This award is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has a firm fixed price of $6,905.40 and an ultimate completion date of April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $5,285.68, has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM8V6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, with a completion date of March 4, 2024 and a potential value of $16,580.00. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/31/24, 9:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 3/1/24 |